海南海药涨2.03%，成交额2666.97万元，主力资金净流入285.67万元

Core Viewpoint - Hainan Haiyao's stock price has shown fluctuations with a year-to-date increase of 15.45%, but recent trends indicate a decline over the past 5, 20, and 60 days [1][2] Company Overview - Hainan Haiyao Co., Ltd. is located in Haikou, Hainan Province, and was established on December 30, 1992, with its stock listed on May 25, 1994 [1] - The company specializes in traditional and Western medicine, fine chemical products, chemical raw materials, health products, and related import-export trade [1] - The revenue composition includes: Other varieties 29.93%, Gastrointestinal health 25.07%, Medical services 18.60%, Raw materials and intermediates 13.27%, Cephalosporin series 10.19%, Others (supplement) 2.95% [1] Financial Performance - For the first half of 2025, Hainan Haiyao reported revenue of 450 million yuan, a year-on-year decrease of 24.12%, while the net profit attributable to shareholders was -158 million yuan, an increase of 20.97% year-on-year [2] - The company has cumulatively distributed 466 million yuan in dividends since its A-share listing, with no distributions in the past three years [3] Shareholder Information - As of September 20, 2025, the number of shareholders is 74,900, a decrease of 1.86% from the previous period, with an average of 15,560 circulating shares per person, an increase of 1.89% [2] - Notable institutional shareholders include: - GF Healthcare Stock A (004851) as the fifth largest shareholder with 11.73 million shares, a new entry - Hong Kong Central Clearing Limited as the seventh largest shareholder with 7.79 million shares, an increase of 2.40 million shares from the previous period - Huaan Contrarian Strategy Mixed A (040035) as the ninth largest shareholder with 6.01 million shares, also a new entry [3]